These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 17642640)

  • 1. Efficacy of desonide 0.05% cream and lotion in steroid-responsive dermatoses in Indian patients: a post-marketing surveillance study.
    Bhankharia DA; Sanjana PH
    Indian J Dermatol Venereol Leprol; 2004; 70(5):288-91. PubMed ID: 17642640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of desonide hydrogel 0.05% on the hypothalamic-pituitary-adrenal axis in pediatric subjects with moderate to severe atopic dermatitis.
    Eichenfield LF; Basu S; Calvarese B; Trancik RJ
    Pediatr Dermatol; 2007; 24(3):289-95. PubMed ID: 17542883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview on desonide 0.05%: a clinical safety profile.
    Wong VK; Fuchs B; Lebwohl M
    J Drugs Dermatol; 2004; 3(4):393-7. PubMed ID: 15303783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents.
    Kimball AB; Gold MH; Zib B; Davis MW;
    J Am Acad Dermatol; 2008 Sep; 59(3):448-54, 454.e1. PubMed ID: 18539358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of adapalene gel 0.1% in acne vulgaris: results of a post-marketing surveillance study.
    Percy SH
    Indian J Dermatol Venereol Leprol; 2003; 69(4):277-80. PubMed ID: 17642911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pimecrolimus 1% cream for the treatment of steroid-induced rosacea: an 8-week split-face clinical trial.
    Lee DH; Li K; Suh DH
    Br J Dermatol; 2008 May; 158(5):1069-76. PubMed ID: 18363758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desonide: a review of formulations, efficacy and safety.
    Kahanek N; Gelbard C; Hebert A
    Expert Opin Investig Drugs; 2008 Jul; 17(7):1097-104. PubMed ID: 18549345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
    Murrell DF; Calvieri S; Ortonne JP; Ho VC; Weise-Riccardi S; Barbier N; Paul CF
    Br J Dermatol; 2007 Nov; 157(5):954-9. PubMed ID: 17935515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of clinical efficacy and safety of once daily topical administration of 1% oxiconazole cream and lotion in dermatophytosis : an open label, non comparative multicentre study.
    Jerajani HR; Amladi ST; Bongale R; Adepu V; Tendolkar UM; Sentamilselvi G; Janaki VR; Janaki C; Vidhya S; Marfatia YS; Patel K; Sharma N; Cooverji ND
    Indian J Dermatol Venereol Leprol; 2000; 66(4):188-92. PubMed ID: 20877072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrocortisone butyrate 0.1% lotion in the treatment of atopic dermatitis in pediatric subjects.
    Matheson R; Kempers S; Breneman D; Draelos Z; Johnson CE; Loss R; Hogan DJ; Schoenfeld R; Checketts S; Kircik L; Fivenson D; Hebert AA; Williams J; Hamlin R; Groisser D; Piacquadio D
    J Drugs Dermatol; 2008 Mar; 7(3):266-71. PubMed ID: 18380208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
    Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
    Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the efficacy, safety and tolerability of Tacrolimus ointment in Indian patients of moderate to severe atopic dermatitis: a multicentric, open label, phase III study.
    Saple DG; Torsekar RG; Pawanarkar V; Wali V; Ravichandran G; Dhanalakshmi UR; Dongre N; Ballary C; Desai A
    Indian J Dermatol Venereol Leprol; 2003; 69(6):396-400. PubMed ID: 17642950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, cutaneous tolerance and cosmetic acceptability of desonide 0.05% lotion (Desowen) versus vehicle in the short-term treatment of facial atopic or seborrhoeic dermatitis.
    Freeman S; Howard A; Foley P; Rosen R; Wood G; See JA; Gray S
    Australas J Dermatol; 2002 Aug; 43(3):186-9. PubMed ID: 12121395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
    Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
    Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of desonide hydrogel 0.05% in pediatric subjects with atopic dermatitis.
    Hebert AA; Cook-Bolden FE; Basu S; Calvarese B; Trancik RJ;
    J Drugs Dermatol; 2007 Feb; 6(2):175-81. PubMed ID: 17373176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desonide foam 0.05%: safety in children as young as 3 months.
    Hebert AA;
    J Am Acad Dermatol; 2008 Aug; 59(2):334-40. PubMed ID: 18638631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study to evaluate the efficacy and safety of hydrocortisone aceponate 0.127% lipophilic cream in steroid responsive dermatoses in Indian patients.
    Mukhopadhyay AK; Baghel V
    Indian J Dermatol Venereol Leprol; 2010; 76(5):591. PubMed ID: 20827017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with pimecrolimus cream 1% clears irritant dermatitis of the periocular region, face and neck.
    Mensing CO; Mensing CH; Mensing H
    Int J Dermatol; 2008 Sep; 47(9):960-4. PubMed ID: 18937664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
    J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
    Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
    Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.